{"nct_id":"NCT03386474","title":"Study of Safety and Efficacy of Brolucizumab 6 mg Drug Product Intended for Commercialization in Patients With nAMD","status":"COMPLETED","status_verified_date":"2020-03","start_date":"2018-01-15","start_date_type":"ACTUAL","primary_completion_date":"2018-09-06","primary_completion_date_type":"ACTUAL","completion_date":"2018-09-06","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["NVS"]}